DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slid 1.86% to $7.40 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.00% to 18,737.21 and Dow Jones Industrial Average falling 0.61% to 41,603.07.
Corbus Pharmaceuticals Holdings Inc. closed 88.05% below its 52-week high of $61.90, which the company achieved on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 2.12% to $4.33, Fortress Biotech Inc. (FBIO) rose 2.89% to $1.78, and Viking Therapeutics Inc. $(VKTX)$ fell 2.70% to $26.98.
Data source: Dow Jones Market Data, FactSet. Data compiled May 23, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 23, 2025 17:25 ET (21:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。